A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM

Part of paid clinical trials in Redwood City, California.

Sponsor
Lexeo Therapeutics
Study ID
NCT06976606
Status
Recruiting
Apply to this trial

Conditions

  • Arrhythmogenic Cardiomyopathy
  • PKP2-ACM
  • PKP2-ARVC

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Study Details

An observational study to assess real-world patient characteristics and clinical course of disease in participants with PKP2-ACM.

Key Dates

Start date
Jan 23, 2024
Status verified
May 2025
Primary completion
Jul 31, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
40 participants (estimated)

Primary Outcome Measure

Premature ventricular contractions (PVC) [ Time Frame: 12 months ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
Leland Stanford Junior UniversityRedwood CityCalifornia94063-3126
Priya Nair
[email protected]
512-217-3812
Johns Hopkins UniversityBaltimoreMaryland21287
Crystal Tichnell
[email protected]
410-502-7161
Northshore University Healthsystem Research InstituteColumbiaMaryland21044
University of MichiganAnn ArborMichigan48109
Muhammad Hussain
[email protected]
734-765-8217
Henry Ford HospitalDetroitMichigan48202
University of RochesterRochesterNew York14642

Find similar trials in Redwood City, CA

By research site
Leland Stanford Junior University· Redwood City, CAJohns Hopkins University· Baltimore, MDNorthshore University Healthsystem Research Institute· Columbia, MDUniversity of Michigan· Ann Arbor, MIHenry Ford Hospital· Detroit, MIUniversity of Rochester· Rochester, NY

Related Studies